Cargando…

Targeting coagulation to unlock antitumor immunity?

Besides a number of physical consequences (reduced blood supply, stabilization of circulating tumor microemboli, shielding from the attack of immune cells), the coagulation cascade may specifically regulate antitumor immunity. We recently applied systems biology and genomics to explore the regulatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galmiche, Antoine, Saidak, Zuzana, Ghiringhelli, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Author’s View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890431/ https://www.ncbi.nlm.nih.gov/pubmed/35251772 http://dx.doi.org/10.1080/2162402X.2022.2045696

Ejemplares similares

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
por: Thibaudin, Marion, et al.
Publicado: (2023)

Immune ambivalence: The schizophrenic bleomycin
por: Mignot, Grégoire, et al.
Publicado: (2013)

Immune effects of 5-fluorouracil: Ambivalence matters
por: Ghiringhelli, François, et al.
Publicado: (2013)

Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)

Retinoic acid on stage in antitumor immunity
por: Guo, Yanxia, et al.
Publicado: (2013)

Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
por: Thomas, Lawrence J, et al.
Publicado: (2014)

MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022)

Catechins and antitumor immunity: Not MDSC’s cup of tea
por: Santilli, Giorgia, et al.
Publicado: (2013)

Crucial role of inflammatory monocytes in antitumor immunity
por: Pommier, Arnaud, et al.
Publicado: (2013)

Engineering effective T-cell based antitumor immunity
por: Gruber, Thomas, et al.
Publicado: (2013)

Potentiating antitumor immunity with αGC-loaded exosomes
por: Gehrmann, Ulf, et al.
Publicado: (2013)

Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
por: Mikucki, Maryann E., et al.
Publicado: (2016)

High endothelial venules: Help or hindrance in the quest for antitumor immunity?
por: Gallimore, Awen, et al.
Publicado: (2013)

Activation of systemic antitumor immunity via TRAIL-induced apoptosis
por: James, Britnie R., et al.
Publicado: (2012)

Dacarbazine mediates antimelanoma effects via NK cells
por: Hervieu, Alice, et al.
Publicado: (2013)

Induction of pyroptosis in colon cancer cells by LXRβ
por: Rébé, Cédric, et al.
Publicado: (2015)

A Janus-faced role of the unfolded protein response in antitumor immunity
por: Mahadevan, Navin R., et al.
Publicado: (2013)

Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013)

B7-H4 is a positive regulator of antitumor immunity
por: Rahbar, Ramtin, et al.
Publicado: (2015)

A clinically useful approach to enhance immunological memory and antitumor immunity
por: Berezhnoy, Alex, et al.
Publicado: (2014)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
por: Gujar, Shashi A, et al.
Publicado: (2014)

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response
por: Sosnowska, Anna, et al.
Publicado: (2019)

Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
por: Roberti, Maria Paula, et al.
Publicado: (2020)

The short and sweet of T-cell therapy: Restraining glycolysis enhances the formation of immunological memory and antitumor immune responses
por: Sukumar, Madhusudhanan, et al.
Publicado: (2014)

Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition
por: Kim, Hyung L
Publicado: (2014)

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
por: Schalper, Kurt A
Publicado: (2014)

Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses
por: Anderson, John, et al.
Publicado: (2012)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4(+) T-cell maturation
por: Brisson, Lydie, et al.
Publicado: (2015)

Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies
por: Verbrugge, Inge, et al.
Publicado: (2012)

Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide
por: Chen, Xin, et al.
Publicado: (2014)

Arming NK cells with enhanced antitumor activity: CARs and beyond
por: Oberoi, Pranav, et al.
Publicado: (2013)

Role of the complement system in NK cell-mediated antitumor T-cell responses
por: Janelle, Valérie, et al.
Publicado: (2014)

BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013)

A road less traveled paved by IDO silencing: Harnessing the antitumor activity of neutrophils
por: Manuel, Edwin R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_guj0bvrqk7crg0e2jlmrrnrh2f